Video Experimental Relacionado
Updated: May 23, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
MYC en el camino hacia el cáncer
1Division of Hematology-Oncology, Department of Medicine, Abramson Cancer Center, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. dangvchi@upenn.edu
Cell
|April 3, 2012
Resumen
Dirigirse al oncogén MYC ofrece nuevas estrategias de tratamiento del cáncer. La inhibición de la activación de MYC o sus efectos posteriores pueden detener el crecimiento tumoral, presentando nuevas oportunidades terapéuticas para varios tipos de cáncer.
Área de la Ciencia:
- Oncología Oncología.
- Biología Molecular Biología Molecular
- La bioquímica es la bioquímica.
Sus antecedentes:
- El oncogén MYC es un motor importante en el desarrollo de numerosos cánceres humanos.
- Comprender la expresión y la función de MYC es crucial para desarrollar terapias efectivas contra el cáncer.
Objetivo del estudio:
- Revisar los conocimientos actuales sobre el MYC en el cáncer.
- Para resaltar nuevos conocimientos biológicos y estrategias terapéuticas dirigidas a MYC.
Principales métodos:
- Revisión de la literatura científica reciente sobre el oncogén MYC.
- Análisis de enfoques terapéuticos dirigidos a la activación, la dimerización y las vías metabólicas del MYC.
Principales resultados:
- La activación de MYC por las proteínas bromodomaínas puede ser inhibida por pequeñas moléculas, lo que lleva a la supresión tumoral in vivo.
- Dirigirse al metabolismo de la glucosa o la glutamina puede desacoplar la acumulación de biomasa impulsada por el MYC.
- La inhibición de la dimerización de Myc-Max o la expresión de microARN inducida por MYC son vías terapéuticas alternativas.
Conclusiones:
- Una comprensión más profunda de la biología de MYC proporciona nuevas vías para el tratamiento del cáncer.
- Dirigirse a MYC ofrece oportunidades terapéuticas prometedoras para diversos tipos de cáncer en humanos.
Videos de Conceptos Relacionados
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...